(Q40773385)

23 September 2017

1 reference

title

Mechanism of induction of chromosomal aberrations by inhibitors of DNA topoisomerases (English)

1 reference

23 September 2017

Palitti F

1

1 reference

23 September 2017

publication date

1 January 1993

1 reference

Environmental and Molecular Mutagenesis

23 September 2017

published in

1 reference

23 September 2017

volume

22

1 reference

23 September 2017

issue

4

1 reference

23 September 2017

page(s)

275-277

1 reference

Molecular mechanisms involved in the production of chromosomal aberrations. I. Utilization of Neurospora endonuclease for the study of aberration production in G2 stage of the cell cycle

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEM.2850220416

The production of chromosomal alterations in human lymphocytes by drugs known to interfere with the activity of DNA topoisomerase II. I. m-AMSA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEM.2850220416

7 January 2021

Induction of chromosomal aberrations and SCE by camptothecin, an inhibitor of mammalian topoisomerase I

1 reference

https://api.crossref.org/works/10.1002%2FEM.2850220416

7 January 2021

DNA topoisomerases as targets for cancer therapy

1 reference

https://api.crossref.org/works/10.1002%2FEM.2850220416

7 January 2021

DNA topoisomerase dysfunction: a new goal for antitumor chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FEM.2850220416

7 January 2021

https://api.crossref.org/works/10.1002%2FEM.2850220416

1 reference

7 January 2021

Protein-associated deoxyribonucleic acid strand breaks in L1210 cells treated with the deoxyribonucleic acid intercalating agents 4'-(9-acridinylamino) methanesulfon-m-anisidide and adriamycin

1 reference

https://api.crossref.org/works/10.1002%2FEM.2850220416

7 January 2021

Identifiers

DOI

10.1002/EM.2850220416

1 reference

23 September 2017

1 reference